| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
mcgill_interdisciplinary_initiative_in_infection_and_immunity [2023/05/17 01:44]
liam | mcgill_interdisciplinary_initiative_in_infection_and_immunity [2023/05/19 19:53] (current)
liam |
|---|
| ==== COVID-19 ==== | ==== COVID-19 ==== |
| |
| MI4 provided research funding related to [[COVID-19]] through their "MI4 Emergency COVID-19 Research Funding" program.((//Results of MI4 Emergency COVID-19 Research Funding.// MI4. Retrieved May 16, 2023, from https://web.archive.org/web/20230516234033/https://www.mcgill.ca/mi4/mi4-supported-research/emergency-covid-19-research-funding)) In particular, MI4 participated as a funding partner of the Canadian arm of the first [[randomized control trial]] (RCT) testing [[hydroxychloroquine]] for the post-exposure prevention of COVID-19, which began on March 17, 2020.((Lofgren, S. M., Nicol, M. R., Bangdiwala, A. S., Pastick, K. A., Okafor, E. C., Skipper, C. P., Pullen, M. F., Engen, N., Abassi, M., Williams, D. A., Nascene, A. A., Axelrod, M. L., Lother, S. A., MacKenzie, L. J., Drobot, G., Marten, N., Cheng, M. P., Zarychanshi, R., Schwartz, I. S., & Silverman, M. J. (2020). //Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19.// medRxiv. https://doi.org/10.1101/2020.07.16.20155531)) | MI4 provided research funding related to [[COVID-19]] through their "MI4 Emergency COVID-19 Research Funding" program.((//Results of MI4 Emergency COVID-19 Research Funding.// MI4. Retrieved May 16, 2023, from https://web.archive.org/web/20230516234033/https://www.mcgill.ca/mi4/mi4-supported-research/emergency-covid-19-research-funding)) In particular, MI4 participated as a funding partner of the Canadian arm of the first [[randomized control trial]] (RCT) testing [[hydroxychloroquine]] for the post-exposure prevention of COVID-19, led by principal investigator [[David Boulware]], which began on March 17, 2020.((Lofgren, S. M., Nicol, M. R., Bangdiwala, A. S., Pastick, K. A., Okafor, E. C., Skipper, C. P., Pullen, M. F., Engen, N., Abassi, M., Williams, D. A., Nascene, A. A., Axelrod, M. L., Lother, S. A., MacKenzie, L. J., Drobot, G., Marten, N., Cheng, M. P., Zarychanshi, R., Schwartz, I. S., & Silverman, M. J. (2020). //Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19.// medRxiv. https://doi.org/10.1101/2020.07.16.20155531)) |
| | |
| | In December 2020, MI4 announced that it had received a $600,000 gift from [[pharmaceutical_companies:Pfizer]] via [[McGill University]] and the [[McGill University Health Centre Foundation]] towards the creation of the Pfizer Early Career Investigator Awards.((Clement, J., & Schwartz, T. (2020, December 4). //Pfizer Canada donation will help new researchers change the future.// McGill University Faculty of Medicine and Health Sciences. http://archive.today/2022.08.23-174216/https://www.mcgill.ca/medhealthsci/channels/news/pfizer-canada-donation-will-help-new-researchers-change-future-326710)) |
| |
| ===== Organization ===== | ===== Organization ===== |
| ==== Funding ==== | ==== Funding ==== |
| |
| MI4 received funding for their "MI4 Emergency COVID-19 Research Funding" program from:((//Results of MI4 Emergency COVID-19 Research Funding.// MI4. Retrieved May 16, 2023, from https://web.archive.org/web/20230516234033/https://www.mcgill.ca/mi4/mi4-supported-research/emergency-covid-19-research-funding)) | MI4 received funding for their "MI4 Emergency COVID-19 Research Funding" program through the [[McGill University Health Centre Foundation]] COVID-19 Emergency Fund from:((//Results of MI4 Emergency COVID-19 Research Funding.// MI4. Retrieved May 16, 2023, from https://web.archive.org/web/20230516234033/https://www.mcgill.ca/mi4/mi4-supported-research/emergency-covid-19-research-funding)) |
| | |
| | * [[Alliance of Québec Chinese Associations]] |
| | * [[Behaviour Interactive]] |
| | * [[Future Electronics]] |
| | * [[Gulshan & Pyarali G. Nanji Family Foundation]] |
| | * [[Henry and Berenice Kaufmann Foundation]] |
| | * [[Hewitt Foundation]] |
| | * [[Mike & Valeria Rosenbloom Foundation]] |
| | * [[Montreal Children's Hospital Foundation]] |
| | * [[Montreal General Hospital Foundation]] |
| | * [[Power Corporation of Canada]] |
| | * [[Québec Blue Cross]] |
| | * [[Rossy Foundation]] |
| | * [[Trottier Family Foundation]] |
| | |
| | ===== Activities ===== |
| | |
| | ^ MI4 Overcoming Barriers to COVID-19 Vaccination Research Funding Program((//Results of MI4 Overcoming Barriers to COVID-19 Vaccination Research Funding Program.// MI4. Retrieved May 17, 2023, from https://web.archive.org/web/20230517045026/https://www.mcgill.ca/mi4/mi4-supported-research/covid-19-vaccination-research-funding-program)) ^^ |
| | ^ Lead investigators ^ Project title ^ |
| | | [[Nadine Kronfli]] | The design, delivery, and evaluation of an educational intervention to increase COVID-19 vaccine uptake for incarcerated Canadian populations | |
| | | [[Inés Colmegna]] | Preparing Adults for COVID-19 Vaccine – PROVIDE-A | |
| | | [[Zeev Rosberger]] | Enhancing COVID-19 Vaccination Intentions by Eliciting Prosocial Altruistic Motives: Evaluating the Efficacy of a Brief Video-Based Intervention | |
| | | [[Ian Gold]] | Overcoming COVID-19 [[Vaccine Hesitancy]] | |
| | | [[Abhinav Sharma]] | COVID-19 Vaccination Among Cardiovascular Patients and High Risk Individuals (COVID-CPR): Identifying and Addressing Barriers in Quebec | |
| | | [[Moshe Ben-Shoshan]] | COVERS: COVID Vaccine Evaluation of Resources and Solutions | |
| | ^ MI4 Emergency COVID-19 Research Funding((//Results of MI4 Emergency COVID-19 Research Funding.// MI4. Retrieved May 16, 2023, from https://web.archive.org/web/20230516234033/https://www.mcgill.ca/mi4/mi4-supported-research/emergency-covid-19-research-funding)) ^^ |
| | ^ MI4 COVID-19 Strategic Funding Grants ^^ |
| | ^ Lead investigators ^ Project title ^ |
| | | [[Peter Goldberg]] | The use of volatile anesthetics in COVID-19 intubated patients: A pilot study | |
| | | [[Vincent Mooser]] | Extensive and Longitudinal Proteomic Profiling in Plasma from Severe COVID19 Patients | |
| | | [[Cécile Rousseau]], [[Alexandra de Pokomandy]] | [[CanCOVID]] - COVID‐19 Outreach and Communications for Marginalized Communities in [[canada:quebec:Montreal]] | |
| | | [[Guillaume Bourque]] | CanCOVID - Scientific volunteer support for Canadian COVID-19 research and community needs | |
| | | [[Dominic Frigon]] | CanCOVID - Sequencing approaches of SARS-CoV-2 in wastewater to optimize population-level surveillance and enhance epidemiology of COVID-19 | |
| | | [[Don Vinh]] | Host-directed [[Immunotherapy]] to Fight [[Infectious diseases]] (HI-FI) | |
| | | [[Dick Menzies]], [[Jonathon Campbell]] | COVID-19 Targeted Community Testing | |
| | | [[David Juncker]] | Rapid and Sensitive Diagnostic Test for COVID-19 Using Saliva | |
| | ^ MI4 ECRF Round 1 ^^ |
| | | [[Matthew Cheng]], [[Leighanne Parkes]], [[Todd Lee]], [[Emily McDonald]] | A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients in Canada (CATCO) | |
| | | [[Matthew Cheng]], [[Erwin Schurr]], [[Guillaume Bourque]] | Genomic biomarkers to predict outcome and treatment response in hospitalized COVID-19 patients | |
| | | [[Jörg H. Fritz]], [[Ciriaco Piccirillo]] | Defining the protective host immune response to SARS-CoV-2 | |
| | | [[John Hanrahan]] | Targeting coronavirus cation channels with antiviral drugs | |
| | | [[Lara Khoury]], [[Alana Klein]], [[Marie-Eve Couture-Ménard]] | Law in Pandemic Times: Powers and Accountability when Facing Emergency | |
| | | [[Irah King]] | Targeting the gut microbiome to improve COVID-19 disease outcomes | |
| | | [[Todd Lee]], [[Emily McDonald]], [[Matthew Cheng]] | Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial (COVID19 PEP RCT – Canada) | |
| | | [[Mathieu Maheu-Giroux]], [[Dimitra Panagiotoglou]], [[Alexandra Schmidt]], [[Nicole Basta]], [[David Buckeridge]], [[Yiqing Xia]], [[Arnaud Godin]], [[Dirk Douwes-Schultz]] | Real-time modeling of COVID-19 transmission in Canada: epidemic intelligence for an effective public health response | |
| | | [[Sara Mahshid]] | Colorimetric assisted microfluidic device for detection of SARS-Cov2 RNA | |
| | | [[Dick Menzies]], [[Jonathon Campbell]] | Assessing costs and benefits of different testing strategies for COVID-19 in Canada | |
| | | [[Nicolas Moitessier]], [[Anthony Mittermaier]] | PLpro as a target for the development of novel anti-COVID-19 agents | |
| | | [[Joaquin Ortega]], [[Duane Chung]], [[C. Perry Chou]] | Development of a new [[Virus-like Particle]] (VLP) vaccine against COVID-19 | |
| | | [[Martin Schmeing]], [[Don van Meyel]] | Production of COVID-19 testing reagents to backstop and supplement existing sources | |
| | | [[Abhinav Sharma]] | Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted in hospital with confirmed coronavirus disease (COVID-19) infection: The McGill RAAS-COVID-19 randomized controlled trial. | |
| | | [[Benjamin Smith]] | PCR-based testing to shorten self-isolation duration in COVID-19 exposed healthcare workers | |
| | | [[Brett Thombs]], [[Linda Kwakkenbos]], [[Andrea Benedetti]], [[Susan Bartlett]], [[John Varga]], [[Scott Patten]], [[Nicole Culos-Reed]], [[Shannon Hebblethwaite]] | Mental health in an at-risk population during COVID-19: longitudinal study of risk factors and outcomes and embedded trial of an activity, education, and support intervention | |
| | ^ MI4 ECRF Round 2 ^^ |
| | | [[Nicole Basta]] | Real-Time Tracking of COVID-19 Vaccine Development | |
| | | [[Inés Colmegna]], [[Amal Bessissow]], [[David Meger]] | Use of Technology to Improve Effects of Social Isolation on Hospitalized [[COVID-19]] Patients (TIES-COVID) | |
| | | [[Gonzalo Cosa]] | Novel Small Molecule [[Antiviral]] Agents for Treatment of [[SARS-CoV-2]] causing COVID 19 coronavirus disease: Target Identification and Structural Optimization | |
| | | [[Kristian Filion]] | [[Anticoagulant]] treatment and risk of adverse outcomes among hospitalized COVID-19 patients | |
| | | [[Patricia Fontela]], [[Jesse Papenburg]] | A Multi-centre, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of [[Hydroxychloroquine]] for the Treatment of COVID-19 in Hospitalized Children in [[Canada]] (CATCO-Kids) | |
| | | [[Jason Harley]], [[Tina Montreuil]] | Emotion Regulation and Healthcare Professionals: Creating Research-informed Solutions | |
| | | [[Lily Hechtman]], [[Philippe Hwang]], [[Lindsay Parr]] | Factors affecting positive and negative adaptation to [[quarantine]] in children and their families during the [[COVID-19 pandemic]] | |
| | | [[Matthew Hunt]] | Ethical tensions of implementing research during a crisis: Understanding moral experiences of healthcare providers caring for patients who are enrolled in CoViD-19 clinical trials | |
| | | [[Jonathan Kimmelman]] | Expert and Lay Perceptions of Translation of COVID19 Treatment and Vaccine Development | |
| | | [[Jonathan Kimmelman]] | Success Rate and Timeline for Development of Vaccines for Emerging and Reemerging Viral Infectious Diseases | |
| | | [[Bertrand Lebouché]] | Use of [[OPAL-COVID]], a mobile application, for real-time at home follow-up of people who test positive for COVID-19 at the Glen site: a feasibility study | |
| | | [[Greg Matlashewski]], [[Matthew Cheng]], [[Momar Ndao]] | Detection of anti- SARS-CoV-2 antibodies in sera from COVID19 patients | |
| | | [[Momar Ndao]], [[Michael Reed]], [[Martin Olivier]] | [[COVID-19 Vaccines]] - Novel Approaches to Tackle a Novel Disease | |
| | | [[Janusz Rak]], [[Maziar Divangahi]], [[Dongsic Choi]] | Exosomal mimetics of COVID-19 as viral models and therapeutics | |
| | | [[Stéphane Rinfret]] | Effect of [[coronavirus]] pandemic and health care system response on non-COVID-19-related mortality, post pandemic [[myocardial infarction]] and [[heart failure]] rates in [[canada:Quebec]]; a collateral damage in this war? | |
| | | [[Cécile Rousseau]] | Health Communication, Sociocultural Diversity, and COVID-19 | |
| | | [[Selena Sagan]], [[Richard Menzies]] | Germicidal ultraviolet light to disinfect personal protective equipment to reduce nosocomial transmission of COVID-19 | |
| | | [[Jonathan Spicer]] | Evaluating Neutrophil Extracellular Traps as a therapeutic target in COVID-19 patients | |
| | | [[Brett Thombs]], [[Andrea Benedetti]] | [[Mental Health]] during the COVID-19 Pandemic: A Living Systematic Review of Symptom Levels, Factors Associated with Symptoms, and Intervention Effectiveness | |
| | | [[David Wachsmuth]] | A spatial analysis of COVID-19 risk and recovery in Canadian cities | |
| | ^ Internal McGill COVID-19 Rapid Response for Social Sciences and Humanities ^^ |
| | | [[Leonardo Baccini]] | The Political Economy of Governments' Response to the COVID-19 Pandemic | |
| | | [[Adelle Blackett]] | COVID-19's Essential Workers: Rethinking Social Protection Beyond the Employment Relationship | |
| | | [[Delphine Collin-Vezina]] | Responding to Child Protection-Involved Families During the COVID-19 Pandemic | |
| | | [[Bassam Khoury]] | Understanding the Impact of the COVID-19 Pandemic on the Canadian Mental Health Care System | |
| | | [[Jennifer Elrick]] | Changing the Social Value of Work? The Effects of Covid-19 on Canada's Seasonal Agricultural Worker Program (SAWP) | |
| | | [[Fabien Gélinas]] | The COVID-19 Crisis: An Investment Law Perspective | |
| | | [[Charles Gladhill]] | Ancient Narratives of Viral Contagion and the Aftermath of COVID-19 | |
| | | [[Warut Khern-am-nuai]] | Helping Retailers and Customers to Cope with Surge Demands Under COVID-19 | |
| | | [[Anthony Masi]] | Differences in Public Policy Responses and Citizens Reactions to the COVID-19 Pandemic: A Comparative Study of [[Canada]], [[Sweden]], [[Italy]] and the [[south_korea|Republic of Korea]] | |
| | | [[Ma'n Hilmi Mohammad Zawati]] | Of Biobanking and Policy: Emerging Ethical and Legal Challenges During the COVID-19 Pandemic | |
| | | [[Daiva Nielsen]] | Experiences with Food Acquisition in Quebec During COVID-19 Pandemic: Risk Perceptions, Access Barriers, and Insight to Prepare for the Future | |
| | | [[Juan Camilo Serpa]] | Quebec Data Central for Impact of Covid-19 on Society and Business and for a Post-Pandemic World | |
| |
| ===== External links ===== | ===== External links ===== |
| |
| * [[https://www.mcgill.ca/mi4/|Website]] | * [[https://www.mcgill.ca/mi4/|Website]] |
